rodman renshaw amln msb buy rating omer oncothyreon onty verastem vstm executive overview ahro crystal research amylin twitter crowd sourcing maxim group idenix pharmaceuticals idix soligenix sngx speculative outperform mesoblast diabetes bell potter nbs drug development athx ami astm piper jaffray omnipod insulet podd thinkequity drrx affy lazard target price omeros corp cowen buy coverage jp morgan zytiga provenge dndn
Tout plus